(LOS ANGELES)Abraxis BioScience Inc. said Friday a subsidiary bought more than 15 million common shares of ProMetic Life Sciences Inc., giving it a 4 percent stake in the Canadian biotech compa...READ MORE
(LOS ANGELES)Abraxis BioScience Inc. said Thursday it has reached an agreement with ProMetic Life Sciences Inc. to develop and market four biotech drugs. Abraxis said its potential revenue from...READ MORE
(LOS ANGELES)Abraxis BioScience Inc. shares fell more than 4 percent Wednesday after the company reported a deeper second-quarter loss driven largely by research and development and litigation ...READ MORE
(LOS ANGELES)Biotechnology company Abraxis BioScience Inc. said Wednesday that it named David O'Toole to succeed Lisa Gopala as chief financial officer and executive vice president.READ MORE
(LOS ANGELES)Abraxis BioScience Inc. said Thursday it swung to a first-quarter profit , helped by higher sales of the breast cancer treatment Abraxane. The company earned $4.3 million or 11 cen...READ MORE
(LOS ANGELES)Abraxis BioScience Inc. said Tuesday its fourth-quarter loss widened as a slew of hefty costs offset surging drug sales. The biopharmaceutical company posted a loss of $5.2 million...READ MORE